|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Diaz-Garcia CV, Agudo-López A, Pérez C,
López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A,
Martínez-Villanueva M, Iglesias L, García-Carbonero R, et al:
DICER1, DROSHA and miRNAs in patients with non-small cell lung
cancer: Implications for outcomes and histologic classification.
Carcinogenesis. 34:1031–1038. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim VN and Nam JW: Genomics of microRNA.
Trends in genetics. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Puissegur MP, Mazure NM, Bertero T,
Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K,
Cardinaud B, Hofman V, et al: miR-210 is overexpressed in late
stages of lung cancer and mediates mitochondrial alterations
associated with modulation of HIF-1 activity. Cell death and
differentiation. 18:465–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei F, Cao C, Xu X and Wang J: Diverse
functions of miR-373 in cancer. J Transl Med. 13:1622015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-kappaB and TGF-beta signaling pathways. Oncogene. 31:4150–4163.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bing Z, Master SR, Tobias JW, Baldwin DA,
Xu XW and Tomaszewski JE: MicroRNA expression profiles of seminoma
from paraffin-embedded formalin-fixed tissue. Virchows Arch.
461:663–668. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pandey P, Sliker B, Peters HL, Tuli A,
Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, et
al: Amyloid precursor protein and amyloid precursor-like protein 2
in cancer. Oncotarget. 7:19430–19444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim S, Yoo BK, Kim HS, Gilmore HL, Lee Y,
Lee HP, Kim SJ, Letterio J and Lee HG: Amyloid-beta precursor
protein promotes cell proliferation and motility of advanced breast
cancer. BMC cancer. 14:9282014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Botelho MG, Wang X, Arndt-Jovin DJ, Becker
D and Jovin TM: Induction of terminal differentiation in melanoma
cells on downregulation of beta-amyloid precursor protein. J Invest
Dermatol. 130:1400–1410. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sobol A, Galluzzo P, Weber MJ, Alani S and
Bocchetta M: Depletion of amyloid precursor protein (APP) causes G0
arrest in non-small cell lung cancer (NSCLC) cells. J Cell Physiol.
230:1332–1341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew
KP, Wu YL and Zhang S: MiR-373 targeting of the Rab22a oncogene
suppresses tumor invasion and metastasis in ovarian cancer.
Oncotarget. 5:12291–12303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xing RC, Zheng J, Zheng WH, Qin ZP, Liu W
and Yao RC: Relevance of E-cadherin expression to EGFR-TKI
molecular targeted therapy sensitivity/resistance and its clinical
significance. Genet Mol Res. 14:5785–5792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steuer CE, Khuri FR and Ramalingam SS: The
next generation of epidermal growth factor receptor tyrosine kinase
inhibitors in the treatment of lung cancer. Cancer. 121:E1–E6.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ellis PM, Coakley N, Feld R, Kuruvilla S
and Ung YC: Use of the epidermal growth factor receptor inhibitors
gefitinib, erlotinib, afatinib, dacomitinib and icotinib in the
treatment of non-small-cell lung cancer: A systematic review. Curr
Oncol. 22:e183–e215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seol HS, Akiyama Y, Shimada S, Lee HJ, Kim
TI, Chun SM, Singh SR and Jang SJ: Epigenetic silencing of
microRNA-373 to epithelial-mesenchymal transition in non-small cell
lung cancer through IRAK2 and LAMP1 axes. Cancer Lett. 353:232–241.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gyorffy B, Surowiak P, Budczies J and
Lanczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PloS one. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
